Sakamoto, Shinichi
Sato, Kodai
Kimura, Takahiro
Matsui, Yoshiyuki
Shiraishi, Yusuke
Hashimoto, Kohei
Miyake, Hideaki
Narita, Shintaro
Miki, Jun
Matsumoto, Ryuji
Kato, Takuma
Saito, Toshihiro
Tomida, Ryotaro
Shiota, Masaki
Joraku, Akira
Terada, Naoki
Suekane, Shigetaka
Kaneko, Tomoyuki
Tatarano, Shuichi
Yoshio, Yuko
Yoshino, Takayuki
Nishiyama, Naotaka
Kawakami, Eiryo
Ichikawa, Tomohiko
Kitamura, Hiroshi
Funding for this research was provided by:
Grant-in-Aid for Scientific Research (20H03813)
Article History
Received: 31 March 2024
Accepted: 25 June 2024
First Online: 3 July 2024
Competing interests
: Shinichi Sakamoto received honoraria from Janssen Inc. Shintaro Narita received honoraria from Janssen, and AstraZeneca Inc. Masaki Shiota received honoraria from Janssen, AstraZeneca, Astellas, Sanofi, and Bayer Inc. and research funding support from Daiichi Sankyo Inc. Takahiro Kimura received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Sanofi, and Takeda Inc. Hiroshi Kitamura received honoraria from Astellas, AstraZeneca, Janssen, Sanofi, and Takeda Inc. and research grant from AstraZeneca Inc. Kohei Hashimoto received honoraria from Astellas, Janssen, Bayer and AstraZeneca Inc. Naoki Terada received honoraria from Janssen, Astellas and Bayer Inc. Hideaki Miyake received honoraria from Astellas, Bayer, Janssen, Sanofi, and Takeda Inc. Akira Joraku, Eiryo Kawakami, Jun Miki, Kodai Sato, Naotaka Nishiyama, Ryotaro Tomida, Ryuji Matsumoto, Shigetaka Suekane, Shuichi Tatarano, Takayuki Yoshino, Takuma Kato, Tomohiko Ichikawa, Tomoyuki Kaneko, Toshihiro Saito, Yoshiyuki Matsui, Yuko Yoshio, Yusuke Shiraishi have no conflict of interest to disclose.